Due to the COVID-19 outbreak, Novartis released a statement requesting that effective today, its associates within the United States, Europe, and Canada to work from home, with the exception of those working in laboratories, manufacturing sites, and in the field.
The measure is valid for 3 weeks until April 3, 2020.
“As the Coronavirus (COVID-19) continues to spread globally, our primary concern at Novartis remains the health and safety of our associates and patients globally, and it is important that we protect them,” according to the statement. The company added that it will continuously assess the situation and adapt accordingly.
Novartis noted that some governments around the world are providing local guidance that is stricter than this Novartis global guidance. In those cases, the local guidance takes precedence.